(Click on image for larger view)
CANCER
Cancer, medically known as malignant neoplasm), is a class of diseases in which a group of cells show the traits of uncontrolled growth (growth and division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). Most cancers form a tumor but some, like leukemia, do not.
Cancer may affect people at all ages, even fetuses, but risk for the more common varieties tends to increase with age. Cancer causes about 13% of all deaths. According to the American Cancer Society, 7.6 million people died from cancer in the world during 2007. Apart from humans, forms of cancer may affect other animals and plants.
Nearly all cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may be randomly acquired through errors in DNA replication, or are inherited, and thus present in all cells from birth. Complex interactions between carcinogens and the host genome may explain why only some develop cancer after exposure to a known carcinogen. New aspects of the genetics of cancer pathogenesis, such as DNA methylation, and microRNAs are increasingly being recognized as important.
Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are often activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are often inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.
Cancer is usually classified according to the tissue from which the cancerous cells originate, as well as the normal cell type they most resemble. These are location and histology, respectively. A definitive diagnosis usually requires the histologic examination of a tissue biopsy specimen by a pathologist, although the initial indication of malignancy can be symptoms or radiographic imaging abnormalities. Most cancers can be treated and some cured, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments.
Get Flash to see this player.
Cytotron & Cancer
RFQMR technology utilizes a totally different approach compared to conventional cancer treatment. Instead of the very high frequency ionising radiation used in radiotherapy, RFQMR uses radio or sub-radio frequency, low power, non-ionising, non thermal electromagnetic waves. The main concern of the therapy is not the immediate destruction of the cancer cells, but rather with the help of the small amount of energy provided to the cell to stop the DNA's uncontrolled mitosis, put the cell in a vegetative state and in time through apoptosis mechanism enabling the body to rid of the cancerous cells in a controlled fashion as all cells are programmed by nature for self destruction over time.
A phase 1 clinical study has been held at the Institute of Aerospace Medicine in Bangalore India between 2004 and 2006 on more than 100 terminal cancer patients. All patients had undergone all possible conventional interventions such as chemotherapy, radiotherapy or surgery prior to Cytotron Treatment and yet the disease cannot be controlled and they are supposed to die within a few days to few months due to cancer. Out of such patients :
- In most of the patients the tumor progression is stopped or reversed
- 78.3% felt symptomatic relief (such as ease of pain, stop using pain killers, no more weight loss etc)
- More than 58% survived more than 1 year
- More than 33.3% went back to normal lives and living disease free for 2 years